Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation

Atherosclerosis

Volumn 149, Issue 1, 2000, Pages 61-67

  Koba, Shinji ^a,b   Pakala, Rajbabu ^a   Katagiri, Takashi ^a   Benedict, Claude R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypercholesterolemia; Mitogen; Serotonin; Vascular smooth muscle cells

Indexed keywords

INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SEROTONIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROTONIN RELEASE; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FREE RADICAL SCAVENGERS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MITOSIS; MUSCLE, SMOOTH, VASCULAR; RABBITS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEROTONIN;

EID: 0033999483     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00298-1     Document Type: Article

References (46)

1. Serruys PW, de Jaegere P, Kiemeneiji F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the Benestent Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Eng J Med 1994;331:489-495.
2. Fischman DL, Leon MB, Baim DS, Shcatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shanknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Eng J Med 1994;331:496-501.
3. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation. 79:1989;1374-1387.
4. Gordon P.C., Gibson C.M., Cohen D.J., Carrozza J.P., Kuntz R.E., Baim D.S. Mechanisms of restenosis and redilation with coronary stents; quantitative angiographic assessment. J. Am. Coll. Cardiol. 21:1993;1166-1174.
5. Campbell J.H., Campbell G.R. The role of smooth muscle cells in atherosclerosis. Curr. Opin. Lipidol. 5:1994;323-330.
6. Steinberg D. Oxidative modification of LDL and atherosclerosis. Circulation. 95:1997;1062-1071.
7. Alaupovic P., Mack W.J., Knight-Gibson C., Hodis H.N. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler. Thromb. Vasc. Biol. 17:1997;715-722.
8. Phillips N.R., Waters D., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
9. Fetkovaska N. Platelet activation by low density lipoprotein and serotonin: effects of calcium antagonist. J. Cardiovasc. Pharmacol. 19(Suppl 3):1992;S25-S28.
10. Shimokawa H., Vanhoutte P.M. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J. Am. Coll. Cardiol. 17:1991;1197-1202.
11. Malyszko J., Urano T., Knofler R., Ihara H., Shimoyama I., Uemura K., Takada Y., Takada A. Correlations between platelet aggregation, fibrinolysis, peripheral and central serotonergic measures in subhuman primates. Atherosclerosis. 110:1994;63-68.
12. 2 and the specific antagonists on vascular smooth muscle cell proliferation. Circulation. 96:1997;2280-2286.
13. Nemecek G.M., Coughlin S.R., Handley D.A., Moskowitz M.A. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA. 83:1986;674-678.
14. Kavanaugh W.M., Williams L.T., Ives H.E., Coughlin S.R. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin sensitive pathway. Mol. Endocrinol. 2:1988;599-605.
15. Lee S.L., Wang W.W., Lanzillo J.J., Fanburg B.L. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary arterial smooth muscle cells in culture. Am. J. Physiol. 226:1994;L46-L52.
16. Parrott D.P., Lockey P.M., Bright C.P. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells. Atherosclerosis. 88:1991;213-218.
17. Aviram M. LDL-platelet interaction under oxidative stress induced macrophage foam cell formation. Thrombosis Haemostasis. 74:1995;560-564.
18. Ferrei L.F. Fraction of plasma lipoprotein: evaluation of preparative methods. Story J.A. Laboratory and Research Methods in Biology and Medicine. 10:1984;133-156 Alan R Liss, New York.
19. Fischer-Dzoga K., Fraser R., Wissler R.W. Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells: Part 1. Effects of lipoprotein fraction of hyperlipemic serum and lymph. Exp. Mol. Pathol. 24:1976;346-359.
20. Fischer-Dzoga K., Wissler R.W. Stimulation of proliferation instationary primary cultures of monkey aortic smooth muscle cells: part 2. Effect of varying concentrations of hyperlipidemic serum and low density lipoproteins of varying dietary fat origins. Atherosclerosis. 24:1976;515-525.
21. Sugano M., Nakashima Y., Matsushima T. et al. Suppression of atherosclerosis in cholesterol-fed rabbits by dilutiazem injection. Arteriosclerosis. 6:1986;237-241.
22. Mahley R.W., Weisgraber K.H., Innerarity T.L. Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidmia. Circ. Res. 35:1974;722-733.
23. St Clair R.W., Randolph R.K., Jokinen M.P., Clarkson T.B., Barakat H.A. Relationship of the plasma lipoprotein and the monocyte-macrophages system on atherosclerosis severity in cholesterol-fed pigeons. Arteriosclerosis. 6:1986;614-626.
24. Parthassarathy S., Quinn M.T., Schwenke D.C., Carew T.E., Steinberg D. Oxidative modification of beta-very low density lipoprotein, potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 9:1989;398-404.
25. Straprans I., Rapp J.H., Pan X.M., Hardman D.A., Feingold K.R. Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 16:1996;533-538.
26. Kusuhara M., Chait A., Cader A., Berck B.C. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 17:1997;141-148.
27. Rosenfeld M.E., Tsukada T., Chait A., Bierman E.L., Gown A.M., Ross R. Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 7:1987;24-34.
28. Libby P., Mioa P., Ordovas J.M., Schaefer E.J. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J. Cell. Physiol. 124:1985;1-8.
29. Stiko-Rahm A., Hultgardh-Nilsson A., Regnstrom J., Hamsten A., Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12:1992;1099-1109.
30. Bjorkerud S., Bjorkerud B. Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vivo. Arterioscler. Thromb. 14:1994;288-298.
31. Scott-Burden T., Resink T.J., Hahn A.W.A., Baur U., boxd R.J., Buhler F.R. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J. Biol. Chem. 264:1989;12582-12589.
32. Chen J.K., Hoshi H., McClure D.B., McKeehan W.L. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J. Cell. Physiol. 129:1986;207-214.
33. Chait A., Ross R., Albers J.J., Bierman E.L. Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA. 77:1980;4084-4088.
34. Ikeda U., Oguchi A., Okada K., Ishikawa S., Saito T., Ikeda M., Kano S., Takahashi M., Shiomi M., Shimada K. Involvement of LDL receptor in the proliferation of vascular smooth muscle cells. Atherosclerosis. 110:1994;87-94.
35. Seewald S., Sachinidis A., Dusing R., Ko Y., Seul C., Epping P., Vetter H. Lysophosphatidic acid and intracellular signaling in vascular smooth muscle cells. Atherosclerosis. 130:1997;121-131.
36. Willerson J.T., Yao S.K., McNatt J., Benedict C.R., Anderson H.V., Golino P., Murphree S.S., Buja L.M. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following following experimental coronary stenosis and endothelial injury. Proc. Natl. Acad. Sci. USA. 88:1991;10624-10628.
37. Fetkovaska N., Fedelesova V., Dzurik R. Low density lipoprotein amplifies the platelet response to serotonin in human plasma. J. Hypertens. 7(Suppl 6):1987;S164-165.
38. Zhao B., Dierichs R., Harrach-Ruprecht B., Winterhorff H. Oxidized LDL induces serotonin release from blood platelets. Am. J. Hematol. 48:1995;285-287.
39. Aviram M., Brook J.G. Selective release from platelet granules induced by plasma lipoproteins. Biochem. Med. 32:1984;30-33.
40. Andrews H.E., Aitkin J.W., Hassall D.G., Skinner V.O., Bruckdorfer K.R. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem. J. 242:1987;559-564.
41. 2. Arterioscler. Thromb. Vasc. Biol. 15:1995;1131-1138.
42. Ardie N.G., Selley M.L., Simons L.A. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis. 76:1989;117-124.
43. Seewald S., Nickenig G., Ko Y., Vetter H., Sachinidis A. Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells. Cardiovas. Res. 36:1997;92-100.
44. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;1344:1383-1389.
45. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica J.W., Arnold J.M., Wun C.C., Davis B.R., Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 335:1996;1001-1009.
46. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlene P.W., McKillop J.H., Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333:1995;1301-1307.